‘A wake-up call’: GPs issued warning over semaglutide prescribing The DoHAC has delivered ‘education letters’ to more than 1000 doctors found to be prescribing the medication under the PBS, but failing to follow the criteria.
Obesity management needs medications on PBS: RACGP The college’s new obesity position statement calls for extra funding to treat the complex condition and for care to be made affordable for more patients.
Examining the pros and cons of semaglutide A new study finds lowered risk of 42 health outcomes and increased risk of 19 for people using GLP-1RAs, highlighting the ‘far-reaching potential’ of the drugs.
World experts urge overhaul of obesity definition The Global Commission on Clinical Obesity says diagnosis must change, setting out new criteria, categories, and calling on doctors to go ‘beyond BMI’.
Australia’s new leading contributor to burden of disease Smoking tobacco has been overtaken by overweight and obesity as the leading modifiable risk factor, according to a new report.
Is it time to trade in BMI for body roundness? GPs need to move away from using BMI as a diagnostic tool, one expert in the field says. So how should patients’ weight risks be calculated?
Mounjaro expanded to include weight management The TGA has approved tirzepatide for the treatment of overweight and obesity for those with comorbidities, via private prescription.
Holistic patient care key for overweight and obesity New education for GPs supporting patients with overweight and obesity aligns with the latest Red Book recommendations.
How should GPs discuss weight with their patients? A high-profile body image advocate wants doctors to stop raising the issue, but clinicians say there are ways to sensitively approach the topic.
Do future healthcare providers show weight bias? New Australian research shows they do, and that this could have a negative impact on people living with obesity or overweight.